Bacillus clausii SIN

Bacillus clausii SIN is a spore-forming probiotic bacterium that produces antimicrobial compounds and bacteriocins to restore healthy gut microbiota. It works by competing with pathogenic bacteria for intestinal binding sites while enhancing immune function through increased antibody production.

Origin & History

Bacillus clausii SIN is a spore-forming probiotic bacterium that naturally inhabits the human intestine and soil. Known for its resilience, it can survive and colonize the gut effectively.

Historical & Cultural Context

Traditionally used in fermented foods, Bacillus clausii has been a part of human diet for centuries, contributing to gut health.

Health Benefits

- Supports intestinal health by balancing gut flora, improving digestion and reducing bloating. - Enhances the body's natural defense mechanism by boosting the production of antibodies, reducing infection risk. - Aids in the breakdown of complex carbohydrates, increasing energy availability by up to 20%. - Produces short-chain fatty acids, which nourish colon cells and reduce inflammation. - Helps in the synthesis of vitamins B and K, crucial for metabolic and bone health. - Reduces symptoms of irritable bowel syndrome by 30% according to recent studies. - Lowers cholesterol levels by binding to bile acids, promoting heart health.

How It Works

Bacillus clausii SIN produces bacteriocins and antimicrobial peptides that selectively inhibit pathogenic bacteria while promoting beneficial microflora growth. The strain enhances intestinal barrier function by stimulating mucin production and tight junction proteins. It modulates immune responses through Toll-like receptor activation, increasing secretory IgA production and T-helper cell differentiation.

Scientific Research

Clinical trials have shown Bacillus clausii SIN's effectiveness in preventing and treating gastrointestinal disorders, and its ability to improve immune function.

Clinical Summary

Clinical trials with 200-400 participants have demonstrated Bacillus clausii's efficacy in reducing antibiotic-associated diarrhea duration by 2-3 days. Studies show significant improvements in digestive symptoms, with 70-80% of subjects reporting reduced bloating and improved bowel regularity within 7-14 days. Research indicates enhanced immune markers including increased secretory IgA levels and reduced respiratory infection frequency. Evidence quality is moderate, with most studies being randomized controlled trials of 4-12 weeks duration.

Nutritional Profile

- Rich in spores that support gut health. - Produces vitamins beneficial for overall health. - Contains enzymes that aid digestion.

Preparation & Dosage

Recommended dosage is 2 billion CFUs per day. Consult a healthcare provider before use.

Synergy & Pairings

Prebiotics, Lactobacillus plantarum, Bifidobacterium longum

Safety & Interactions

Bacillus clausii is generally well-tolerated with minimal side effects, though mild gastrointestinal discomfort may occur initially in sensitive individuals. It can be taken concurrently with antibiotics due to its natural antibiotic resistance properties, making it effective for preventing treatment-associated dysbiosis. No significant drug interactions have been reported, but immunocompromised patients should consult healthcare providers before use. Safety during pregnancy and breastfeeding has not been extensively studied, so caution is advised.